We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $9.37B
1-Year Est. Return 36.4%
This Fund
S&P 500
This Quarter Est. Return
+1.62%
1 Year Est. Return
+36.4%
3 Year Est. Return
+114.29%
5 Year Est. Return
+137.63%
10 Year Est. Return
+535.77%
AUM
$3.67B
AUM Growth
-$9.35M
Cap. Flow
-$34.4M
Cap. Flow %
-0.94%
Top 10 Hldgs %
14.32%
Holding
1,376
New
77
Increased
503
Reduced
565
Closed
124

Top Buys

Rank Stock Value
1
TGT icon
Target
TGT
+$5.22M
2
FIS icon
Fidelity National Information Services
FIS
+$4.88M
3
LHX icon
L3Harris
LHX
+$4.8M
4
UNH icon
UnitedHealth
UNH
+$4.42M
5
GLD icon
SPDR Gold Trust
GLD
+$4.22M

Top Sells

Rank Stock Value
1
CSCO icon
Cisco
CSCO
+$6.15M
2
LLL
L3 Technologies, Inc.
LLL
+$5.21M
3
TWLO icon
Twilio
TWLO
+$4.77M
4
WP
Worldpay, Inc.
WP
+$4.7M
5
TLT icon
iShares 20+ Year Treasury Bond ETF
TLT
+$4.61M

Sector Composition

Rank Sector Weight
1 Technology 13.33%
2 Healthcare 11.6%
3 Financials 11.1%
4 Consumer Discretionary 8.81%
5 Industrials 8.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CIK
1226
Credit Suisse Asset Management Income Fund
CIK
$134M
$63K ﹤0.01%
+20,000
New +$62.9K
S
1227
DELISTED
Sprint Corporation
S
$63K ﹤0.01%
10,251
– –
CNR
1228
DELISTED
Cornerstone Building Brands, Inc.
CNR
$61K ﹤0.01%
10,000
– –
CX icon
1229
Cemex
CX
$16.3B
$60K ﹤0.01%
15,240
+500
+3% +$1.83K
NBR icon
1230
Nabors Industries
NBR
$1.21B
$60K ﹤0.01%
636
-183
-22% -$20.6K
TEUM
1231
DELISTED
Pareteum Corporation
TEUM
$59K ﹤0.01%
45,435
+28,355
+166% +$74.4K
ATNM icon
1232
Actinium Pharmaceuticals
ATNM
$25M
$56K ﹤0.01%
8,176
+300
+4% +$2.09K
NTGN
1233
DELISTED
Neon Therapeutics, Inc. Common Stock
NTGN
$54K ﹤0.01%
31,127
+1,023
+3% +$3.11K
WPG
1234
DELISTED
Washington Prime Group Inc.
WPG
$52K ﹤0.01%
1,387
– –
AMRS
1235
DELISTED
Amyris Inc.
AMRS
$48K ﹤0.01%
+10,000
New +$37.3K
IBRX icon
1236
ImmunityBio
IBRX
$8.1B
$40K ﹤0.01%
32,600
– –
MIND icon
1237
MIND Technology
MIND
$46.2M
$33K ﹤0.01%
1,000
– –
PDLI
1238
DELISTED
PDL BioPharma, Inc.
PDLI
$33K ﹤0.01%
15,188
– –
MDR
1239
DELISTED
McDermott International
MDR
$30K ﹤0.01%
15,288
+2,126
+16% +$13.1K
AREX
1240
DELISTED
Approach Resources Inc.
AREX
$30K ﹤0.01%
217,997
– –
HIMX
1241
Himax Technologies
HIMX
$2.55B
$28K ﹤0.01%
12,240
-2,000
-14% -$5.23K
NGD
1242
DELISTED
New Gold Inc
NGD
$28K ﹤0.01%
28,146
– –
JCP
1243
DELISTED
J.C. Penney Company, Inc.
JCP
$24K ﹤0.01%
27,300
-1,600
-6% -$1.34K
OPK icon
1244
Opko Health
OPK
$1.02B
$21K ﹤0.01%
10,214
-1,500
-13% -$3.06K
ASXC
1245
DELISTED
Asensus Surgical, Inc.
ASXC
$13K ﹤0.01%
1,638
-824
-33% -$11.2K
ATHX
1246
DELISTED
Athersys, Inc. Common Stock
ATHX
$13K ﹤0.01%
400
– –
INDP icon
1247
Indaptus Therapeutics
INDP
$157M
$12K ﹤0.01%
+7
New +$20.8K
DMK
1248
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
$11K ﹤0.01%
229
– –
QUIK icon
1249
QuickLogic
QUIK
$257M
$8K ﹤0.01%
1,631
– –
AMPE
1250
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$5K ﹤0.01%
34
– –
48 49
50
51 52

Similar funds

AC
Allstate Corporation Northbrook, Illinois $9.35B AUM 16.13% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $9.38B AUM 33.37% 1-Year Est. Return
PVI
Partners Value Investments Hamilton, Bermuda $9.34B AUM 12.2% 1-Year Est. Return
WPL
WINDACRE PARTNERSHIP LLC Houston, Texas $9.34B AUM 17.41% 1-Year Est. Return
IAA
Independent Advisor Alliance Charlotte, North Carolina $9.32B AUM 33.19% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
SIM
SRS Investment Management New York $9.47B AUM 60.12% 1-Year Est. Return

Oppenheimer & Co's Q3 2019 Portfolio in Review

As of Q3 2019, Oppenheimer & Co held 1,376 positions worth $3.67B, down 0.25% from $3.68B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Oppenheimer & Co's Q3 2019 filing shows 77 new, 503 increased, 565 reduced and 124 closed positions. Its largest new stake was Aramark: 104,734 shares worth $3.3M. The largest sale was Cisco, an estimated $6.15M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Healthcare and Financials.

  • Oppenheimer & Co's largest Q3 2019 buy was Aramark: 104,734 shares worth $3.3M.
  • Oppenheimer & Co added most to Target in Q3 2019, an estimated $5.22M increase.
  • Oppenheimer & Co's biggest Q3 2019 reduction was Cisco, cutting an estimated $6.15M.
  • Oppenheimer & Co fully exited L3 Technologies, Inc. in Q3 2019, selling an estimated $5.21M.
  • Oppenheimer & Co's ten largest holdings make up 14% of its $3.67B portfolio in Q3 2019.
  • Oppenheimer & Co opened 77 new positions and closed 124 in Q3 2019.
  • Oppenheimer & Co's portfolio value fell 0.25% quarter-over-quarter to $3.67B.

Based on Oppenheimer & Co's 13F filing for Q3 2019, filed 31 Oct 2019.